Review strategic shareholdings each period and reduce holdings with no strategic rationale
First written in FY2019. 4 of 5 entries say "Advanced", first in FY2020. Latest entry: FY2026.
- FY2026AdvancedAnnual report
「Based on a review as of 31 March 2026, the company confirmed that all shares held as of the date of submission of the annual securities report were consistent with its holding policy.」
The company continued its annual review of strategic shareholdings, sold its shares in ENEOS Holdings and acquired shares in JX Metals, and confirmed that the shareholdings held as of the filing date were consistent with its policy. - FY2023AdvancedAnnual report
「Based on a review as of 31 March 2023, the Board of Directors confirmed that all shares held were consistent with the holding policy." Nissui Pharmaceutical Co., Ltd. ― 33,674 In accordance with the company's shareholding policy, all shares were sold during the current fiscal year.」
The company continued its annual reviews and confirmed that all shareholdings were consistent with its policy. It also sold all shares in Nissui Pharmaceutical. - FY2022AdvancedAnnual report
「Based on a review as of 31 March 2022, the company decided to dispose of its holding in 1 company through a sale or other means, having comprehensively determined that continued ownership was not justified, and confirmed that the other shareholdings were consistent with its holding policy.」
The company conducted its annual review of strategic shareholdings and decided on a policy of disposing of its holding in 1 company through a sale or other means because no rationale for ownership was recognized. - FY2020AdvancedAnnual report
「Based on a review as of 31 March 2020, the company decided to dispose of holdings in 3 companies through sales or other means, having comprehensively determined that continued ownership was not justified. The Board of Directors confirmed that the other shareholdings were consistent with its holding policy.」
The company conducted its annual review of strategic shareholdings and decided on a policy of disposing of holdings in 3 companies through sales or other means because no rationale for ownership was recognized. - FY2019First statedAnnual report
「Each fiscal year, the Board of Directors reviews each individual shareholding by considering its quantitative benefits based on transaction volume, qualitative benefits such as management strategy and synergies, and expectations for medium- to long-term development, and makes a comprehensive decision on whether continued ownership is appropriate.」
The company made a comprehensive disclosure for the first time of its policy on strategic shareholdings: annual review by the Board of Directors, sale or reduction of holdings with no recognized rationale for ownership, and dialogue with the investee companies.